2027 MPS Newborn Screening Meeting

Planned and hosted by the University of Minnesota’s MPS Center. 

The 2027 MPS Newborn Screening and Early Detection Meeting is an essential gathering for professionals in genetics, pediatrics, public health, and rare disease research. Hosted by the University of Minnesota’s MPS Center, this event convenes leading global experts to address pressing practice gaps, emerging screening technologies, and the fast-evolving therapeutic landscape in mucopolysaccharidosis (MPS) care.

Early detection in conditions like MPS I (Hurler Syndrome) and MPS II (Hunter Syndrome) is critical to prevent rapid disease progression and irreversible damage. This year’s curriculum bridges foundational knowledge with clinical performance, focusing on four core educational priorities:

• Standardizing Screening & Diagnostic Precision: Critiquing variability in NBS algorithms, result interpretation, and second-tier testing to eliminate diagnostic uncertainty, resolve pseudodeficiencies, and accurately characterize phenotypes in asymptomatic infants.

• Navigating the Evolving Therapeutic Landscape: Evaluating new clinical evidence across enzyme replacement therapy (ERT), hematopoietic stem cell transplantation (HSCT), gene therapy, and other novel platforms to guide individualized treatment plans and tackle neurological manifestations.

• Strengthening Multidisciplinary Care Coordination: Integrating interdisciplinary communication strategies among geneticists, neurologists, transplant teams, pediatricians, and rehabilitation specialists to prevent fragmented care and ensure timely, lifelong management.

• Addressing Persistent Evidence Gaps: Analyzing unresolved questions around genotype-phenotype correlations, predictive biomarkers, timing of interventions, and long-term benefit-risk profiles to refine prognostication and personalized treatment.

Whether you are a clinician, researcher, or patient advocate, the 2027 meeting offers an interactive environment—featuring case-based discussions and expert panels—designed to improve diagnostic accuracy, care delivery, and long-term outcomes for individuals identified through newborn screening programs.

1. Explore the latest research in pulmonary and critical care medicine at an academic quaternary referral center with emphasis on multidisciplinary management of mechanical ventilation, ECMO, ARDS, pneumonia, pulmonary embolism, sepsis, multiorgan failure, and end of life care.
2. Identify current clinical practice strategies and updates in interstitial lung diseases (ILD) with a focus on identifying co-morbidities, interventions that enhance quality of life, including nursing support, patient education on oxygen use, antifibrotic medications, and early integration of palliative care.
3. Identify and discuss state-of-the-art tools in bronchoscopy and pleural interventions.
4. Discuss the guidelines for lung transplant selection and pearls for pre- and post-transplant management.
5. Discuss the latest updates in a broad category of obstructive lung diseases, including asthma, COPD, and bronchiectasis.
6. Discuss the optimal principles of non-invasive ventilation management, including updates in the field of Sleep Medicine.

EARLY BIRD RATES (Through January 29, 2027)

• $500 | Physicians & Industry Professionals

• $100 | Allied Healthcare & Academic Faculty

• $50 | Residents, Fellows, Trainees & Students

• Free | Patients & Families

STANDARD RATES (Starting January 30, 2027)

• $600 | Physicians & Industry Professionals

• $150 | Allied Healthcare & Academic Faculty

• $60 | Residents, Fellows, Trainees & Students

• Free | Patients & Families

Attendance Type: During registration, you will be prompted to select whether you will attend in person or via live webinar.

Registration Policies

• Pre-Registration Deadline: Pre-registration for in-person attendance is requested by April 23, 2027. Late registrants cannot be guaranteed course materials or arrangements. On-site registration is subject to space availability; all on-site registrants must register and pay via credit card on their own device through the CE Portal (cash and checks are not accepted).

• Mandatory Registration: Registration through the CE Portal is required for all attendees, including free/fee-waived categories.

• Special Accommodations: Please submit requests for special accommodations (e.g., dietary restrictions, lactation room access) in advance. On-site requests cannot be guaranteed.

• Cancellation Policy:

  • To receive a refund (minus an administrative fee), written cancellation notice must be received by 4:30 p.m. CT on May 3, 2027.

  • Administrative Fee: $50 for standard registration; $15 for resident, fellow, trainee, and student rates.

  • No refunds will be issued after May 3, 2027.

• Event Cancellation & Liability Disclaimer: The UMN Office of Continuing Professional Development (OCPD) and its activity partners reserve the right to cancel any activity due to unforeseen circumstances. If canceled, full registration fees will be refunded. UMN OCPD and its partners are not responsible for non-refundable travel, hotel, or agency costs incurred by attendees.

Credit Designation Statements

American Medical Association
This activity has been approved for AMA PRA Category 1 Credit™. Determination of exact number of credits is pending.

American Nurses Credentialing Center (ANCC)
This activity is eligible for ANCC contact hours; the number of hours is pending.

Other Healthcare Professionals
Individuals who participate in this CE activity may submit their statement of participation to their appropriate accrediting organizations or state boards for consideration of credit. The participant is responsible for determining whether this activity meets the requirements for acceptable continuing education.

University of Minnesota - McNamara Alumni Center
200 SE Oak Street
Minneapolis, MN 55455

Mitigation of Relevant Financial Relationships

University of Minnesota Continuing Professional Development adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education and has policies in place to ensure balance, independence, objectivity and scientific rigor in all of its educational activities. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities; individuals who fail to complete the disclosure in advance of the course are not eligible to be involved in this course. Specific disclosure information will be shared with learners prior to the start of the course. All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Amy Gaviglio, MS, CGC
Connetics Consulting, LLC

Co-Director

Paul J Orchard, MD
Professor
University of Minnesota

Co-Director

Jennifer A Braun, APRN
Masonic Cancer Center

Planning Committee Member

Elizabeth Braunlin, MD, PhD
University of Minnesota

Planning Committee Member

George Dizikes, PhD
Clinical Consultant - Newborn Screening
Laboratory Quality Assurance, LLC

Planning Committee Member

Julie Beth Eisengart, PhD
Associate Professor, Pediatric Neuropsychologist
University of Minnesota

Planning Committee Member

N. Matthew Ellinwood, DVM
Chief Scientific Officer
National MPS Society

Planning Committee Member

Ashish Gupta, MD
MD, MPH
University of Minnesota

Planning Committee Member

Terri Klein, CNPM MPS
President & CEO
National MPS Society

Planning Committee Member

Troy Lund, MD
University of Minnesota

Planning Committee Member

Shannon Lunn, RN
University of Minnesota

Planning Committee Member

Ownership-Nurse Approved

Bradley Miller, MD, PhD
Professor
University of Minnesota Medical School

Planning Committee Member

Nishitha R Pillai, MB BS
University of Minnesota

Planning Committee Member

Exhibit opportunities will be available - check back soon for more information.